Cited by 8Medical Imaging Techniques and ApplicationsOvarian function and disordersOvarian cancer diagnosis and treatment

The DOI matches its Crossref record; the references it cites are not checked yet.

Relationship between sex hormones levels and 18 F-FDG uptake by the ovaries in premenopausal woman

Open access
Kim, Tae Hee, Kim, Mi Ran, Jung, Yongsik, An, Young-Sil·2019·Radiology and Oncology

Abstract

Background: The study was conducted to evaluate the effect of sex hormones on F-18 fluorodeoxyglucose ( 18 F-FDG) uptake by normal ovaries. Patients and methods: A total of 197 premenopausal women were included in this study. Based on 18 F-FDG positron emission tomography/computed tomography (PET/CT) images obtained from these subjects, the association of ovarian 18 F-FDG uptake with levels of sex hormones, including estradiol, progesterone, testosterone, follicle-stimulating hormone, and luteinizing hormone was investigated. We also analysed the relationship between the menstrual cycle and ovarian 18 F-FDG uptake. Results: The highest ovarian 18 F-FDG uptake occurred at 2 weeks after the onset of menstruation (median maximum standardized uptake value [SUVmax] = 3.40, median mean SUV [SUVmean] = 2.20), and the lowest ovarian 18 F-FDG uptake was observed during the first week of the menstrual cycle (median SUVmax = 1.60, median SUVmean = 1.20). Ovarian 18 F-FDG uptake was weakly positively correlated with progesterone levels ( rho = 0.28, p < 0.001 for SUVmax, rho = 0.30, p < 0.001 for SUVmean), and this pattern was consistently observed in subjects in the follicular-phase group ( rho = 0.29, p = 0.003 for both SUVmax and SUVmean) but not in subjects in the luteal-phase group. Conclusions: Based on PET images, ovarian glucose metabolism in premenopausal women tended to increase slightly with increasing progesterone concentration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2478/raon-2019-0035

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In women, [18F]FDG uptake in ovaries and breast tissue varies with progesterone levels and age.

    “In women, [18F]FDG uptake in the ovaries and breast tissue varies with progesterone levels and age [11,12].”

    From Influences on PET Quantification and Interpretation (2022) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 19 · Cited by 8

Research works printed but not linked: 16

  1. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508. doi: 10.2967/jnumed.107.047787 · DOI
  2. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77; quiz 150-1. doi: 10.1148/radiographics.19.1.g99ja0761 · DOI
  3. Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006; 16: 1054-65. doi: 10.1007/s00330-005-0088-y · DOI
  4. Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-62.
  5. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and post-menopausal patients: assessment by PET/CT. J Nucl Med 2004; 45: 266-71.
  6. Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med 2009; 23: 107-12. doi: 10.1007/s12149-008-0227-z · DOI
  7. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26: 308-14. doi: 10.1016/S0001-2998(96)80006-7 · DOI
  8. Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 2005; 32: 549-56. doi: 10.1007/s00259-004-1703-x · DOI
  9. Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005; 32: 757-63. doi: 10.1007/s00259-005-1771-6 · DOI
  10. Csapo AI, Pinto-Dantas CA. The effect of progesterone on the human uterus. Proc Natl Acad Sci U S A 1965; 54: 1069-76. doi: 10.1073/pnas.54.4.1069 · DOI
  11. Widmaier EP, Raff H, Strang KT. Vander’s human physiology: the mechanisms of body functions. New York: McGraw-Hill Higher Education; 2008.
  12. De Geyter C, De Geyter M, Huber PR, Nieschlag E, Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum Reprod 2002; 17: 933-9. doi: 10.1093/humrep/17.4.933 · DOI
  13. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009; 30: 465-93. doi: 10.1210/er.2009-0006 · DOI · Paper page
  14. Kol S, Ben-Shlomo I, Ruutiainen K, Ando M, Davies-Hill TM, Rohan RM, et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. J Clin Invest 1997; 99: 2274-83. doi: 10.1172/JCI119403 · DOI
  15. Balsara G, Hernandez E. The ovary: normal, physiologic changes, endometriosis, and metastatic tumors. Clinical Gynecologic Pathology. Philadelphia, PA: Saunders. 1995; 404-9.
  16. Zhu Z, Wang B, Cheng W, Cheng X, Cui R, Huo L, et al. Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med 2006; 31: 781-7. doi: 10.1097/01. rlu.0000247261.82757.ea · DOI

Metadata

Authors
Kim, T. H., Kim, M. R., Jung, Y., & An, Y.-S.
Affiliations
  • Ajou University (KR)
  • Department of Obstetrics and Gynecology, Ajou University School of Medicine , Suwon , South Korea
  • Department of Surgery, Ajou University School of Medicine , Suwon , South Korea
Corresponding author
An, Young-Sil
Venue
Radiology and Oncology
Published
2019-09-01
Volume
53
Issue
3
Pages
293-299
ISSN
  • 1318-2099 (ISSN-L)
  • 1581-3207
OpenAlex
W2976278666
Cited by
8
References
19
Citations by year
2025: 3 · 2023: 1 · 2022: 2 · 2021: 2
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • Radiology and Oncology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • AJOU Open Repository (Ajou University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords
FDG uptake, sex hormones, progesterone, estradiol, testosterone, follicle-stimulating hormone, luteinizing hormone, menstrual cycle, follicular phase, luteal phase, premenopausal women
MeSH terms
Positron Emission Tomography Computed Tomography, Adult, Estradiol, Female, Follicle Stimulating Hormone, Glucose, Humans, Luteinizing Hormone, Menstrual Cycle, Middle Aged, Ovary, Progesterone, Retrospective Studies, Testosterone, Time Factors, Premenopause, Statistics, Nonparametric, Radiopharmaceuticals, Fluorodeoxyglucose F18, Gonadal Hormones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review